US Patent Issued to NOVOHEART INTERNATIONAL on Dec. 23 for "Systems and methods for modeling disease and assessing adverse side effects of therapeutics therefor" (Chinese Inventor)

ALEXANDRIA, Va., Dec. 23 -- United States Patent no. 12,503,717, issued on Dec. 23, was assigned to NOVOHEART INTERNATIONAL Ltd. (Kowloon, Hong Kong).

"Systems and methods for modeling disease and assessing adverse side effects of therapeutics therefor" was invented by Ronald A. Li (Hong Kong).

According to the abstract* released by the U.S. Patent & Trademark Office: "The disclosure provides a substrate for the ordered growth and development of cardiomyocytes such as ventricular cardiomyocytes derived from pluripotent stem cells along with methods of culturing the cells on the substrates for use in assays such as cardiotoxicity assays. Further provided are methods for assessing cardiotoxicity using one or more criteria disclosed herein."...